Pomerantz LLP announces that a class action lawsuit has been filed against INSYS Therapeutics, Inc. (“Insys” or the “Company”) (NYSE:INSY) and certain of its officers. The class action, filed in United States District Court, Southern District of New York, and docketed under 17-cv-01954, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired Insys securities between February 23, 2016 and March 15, 2017 both dates inclusive (the “Class Period”), seeking to recover compensable damages caused by defendants’ violations of the Securities Exchange Act of 1934.
If you are a shareholder who purchased Insys securities during the Class Period, you have until May 16, 2017 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll free, ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and number of shares purchased.